Introduction

Metabolic reprogramming allows cancer cells to sustain growth, evade immune surveillance, and resist treatment. This volume moves from the hallmarks of cancer metabolism to its clinical application, examining glycolysis, glutamine, lipid, and nucleotide pathways. It shows how fibroblasts, macrophages, and endothelial cells shape metabolic coupling within the tumor microenvironment, and surveys inhibitors, synthetic lethality, and nanotechnology delivery. Particular attention is given to phytochemicals, metabolomics for biomarker discovery, and precision oncology.

Key Features

• - Links metabolic hallmarks to therapeutic vulnerabilities.
• - Examines metabolic crosstalk among tumor, stromal, and immune cells.
• - Covers phytochemicals as modulators of signaling pathways.
• - Explains metabolomics, sequencing, and liquid biopsy in precision oncology.
• - Applies AI and computational modeling to predict treatment outcomes.
• - Bridges laboratory findings and patient care through trial data.

Target Readership :

Researchers, clinicians, postgraduate students, and pharmaceutical science professionals.